Table: Santen Pharm -2018/19 parent results

SANTEN PHARMACEUTICAL

09/05/2019 07:00

May 9 (Reuters)- 
          Santen Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            176.21          171.87                                
                 (+2.5 pct)      (+9.5 pct)                              
  Operating         32.85           31.30                                
                 (+5.0 pct)      (+0.0 pct)                              
  Recurring         33.19           31.69                                
                 (+4.7 pct)      (+4.3 pct)                              
  Net               28.01           25.44                                
                 (+10.1 pct)     (+1.7 pct)                              
  EPS             68.96 yen       62.58 yen                              
  EPS Diluted     68.76 yen       62.36 yen                              
  Ann Div         26.00 yen       26.00 yen      26.00 yen               
  -Q2 Div         13.00 yen       13.00 yen      13.00 yen               
  -Q4 Div         13.00 yen       13.00 yen      13.00 yen               
  
  NOTE - Santen Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4536.T